Current research has not definitively proven semaglutide causes OCD, but the biological plausibility supports closer clinical observation in high-risk populations
Semaglutide can help by reducing appetite and increasing feelings of fullness
If youre thinking about starting (or stopping) GLP-1 medication, have realistic expectations and speak to an experienced doctor
Researchers compared their findings to landmark clinical trials
Its really important patients who are using this treatment are given full wraparound support by their pharmacy to make the long-term changes to diet and exercise they need to maintain a healthy weight. John Wilding, professor of medicine in the Department of Cardiovascular and Metabolic Medicine at the University of Liverpool, said: The results are not surprising
This phenomenon, sometimes informally called GLP-1 face in aesthetic circles, is not a flaw or a failure